Начало › Рак на гърдата › Флорида › Miami
Клинични проучвания за Рак на гърдата в Miami, FL
42 проучвания за Рак на гърдата търсят участници в обекти в и около Miami (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Набиране на участнициФаза 3
- Dwoskin Proton Therapy Center, Miami
- Miami Cancer Institute, Miami
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Набиране на участнициФаза 3
- Miami Cancer Institute, Miami
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Набиране на участнициФаза 3
- Research Site, Miami
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Набиране на участнициФаза 2
- Sylvester Comprehensive Cancer Center, Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Набиране на участници
- Werheim Cancer Institute, Miami
Precise Oncology Interventions in Nutrition and Training (OnPoint)
Набиране на участнициЗдравите доброволци са добре дошли
- University of Miami, Miami
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Набиране на участнициФаза 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Набиране на участнициЗдравите доброволци са добре дошли
- TopLine MD Alliance, Miami
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Набиране на участнициФаза 2
- Baptist Alliance Miami Cancer Institute, Miami
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- University of Miami (Data Collection Only), Miami
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Набиране на участнициФаза 3
- Miami Cancer Institute at Baptist Health Inc., Miami
- University of Miami, Miami
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Набиране на участнициФаза 1
- University of Miami, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набиране на участнициФаза 1
- University of Miami, Miami
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Набиране на участнициФаза 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Набиране на участнициФаза 1/2
- Sylvester Comprehensive Cancer Center, Miami
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Набиране на участнициФаза 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Набиране на участнициФаза 3
- University Of Miami-SCCC-Miami, Miami
- University of Miami_SCCC - Kendall, Miami
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Набиране на участнициФаза 2
- Miami Cancer Institute/Baptist Hospital of Miami, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набиране на участнициФаза 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
Набиране на участнициФаза 2
- Baptist Health Herbert Wertheim Cancer Institute, Miami
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Набиране на участнициФаза 3
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Набиране на участнициФаза 2
- Miami Baptist Cancer Institute/, Miami
SABER Study for Selected Early Stage Breast Cancer
Набиране на участници
- University of Miami, Miami
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Набиране на участнициФаза 2
- University of Miami Hospital and Clinics, Miami
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Набиране на участнициФаза 3
- Miami Cancer Institute, Miami
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
Набиране на участнициФаза 3
- Baptist Health South Florida, Miami
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- University of Miami, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Набиране на участнициФаза 2
- Miami Cancer Institute at Baptist Health (Kendall), Miami
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Набиране на участнициФаза 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Набиране на участнициФаза 1/2
- Miami Cancer Institute at Baptist Health, Miami
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
Набиране на участници
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Набиране на участнициФаза 2
- Baptist Alliance - McI, Miami
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
Набиране на участници
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набиране на участнициФаза 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Miami Cancer Institute, Miami
Breast Re-irradiation After Second Ipsilateral Lumpectomy
Набиране на участници
- Miami Cancer Institute at Baptist Health, Inc., Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Miami
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Набиране на участнициНаблюдателно проучване
- Sylvester Comprehensive Cancer Center - University of Miami, Miami
- Miami Cancer Institute at Baptist Health, Inc, Miami
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Набиране на участнициФаза 2
- AP Medical Research, Miami
Проучвания за Рак на гърдата в други градове
- New York City, NY134 проучвания
- Houston, TX126 проучвания
- Boston, MA111 проучвания
- Nashville, TN80 проучвания
- Los Angeles, CA72 проучвания
- Edison, NJ68 проучвания
- St. Louis, MO64 проучвания
- Durham, NC63 проучвания
- Queens, NY63 проучвания
- Chicago, IL58 проучвания
- Philadelphia, PA56 проучвания
- Dallas, TX55 проучвания
Други проучвания в Miami
- Рак (всички видове)36 проучвания
- Рак на белия дроб с недребноклетъчен тип31 проучвания
- Рак на простатата27 проучвания
- Затлъстяване27 проучвания
- Остра миелоидна левкемия24 проучвания
- Метастатичен рак24 проучвания
- Рак на яйчниците23 проучвания
- Наднормено тегло23 проучвания
- Множествен миелом21 проучвания
- Язвенен колит21 проучвания
- Болест на Алцхаймер20 проучвания
- Рак на белия дроб20 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.